Jill Marie Broadfoot Acelrx Pharmaceuticals Inc (ACRX) insider trading activity

Jill Marie Broadfoot is of ACELRX PHARMACEUTICALS INC. Currently has a direct ownership of 8,547 shares of ACRX, which is worth approximately $9,658. The most recent transaction as insider was on Oct 23, 2025, when has been sold 4,267 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.55K

99.7% 3M change

99.7% 12M change

Total Value Held $9,658

Jill Marie Broadfoot Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 23 2025	BUY Grant, award, or other acquisition	-	4,267 Added 33.3%	8,547 Common Stock
Jun 24 2024	BUY Grant, award, or other acquisition	-	2,174 Added 33.68%	4,280 Common Stock
Oct 10 2023	BUY Grant, award, or other acquisition	-	581 Added 21.62%	2,106 Common Stock
Jul 15 2022	BUY Grant, award, or other acquisition	-	15,500 Added 33.7%	30,500 Common Stock
Nov 20 2021	BUY Grant, award, or other acquisition	-	15,000 Added 50.0%	15,000 Common Stock

Also insider at

OTIC

OTONOMY, INC. Healthcare

Director

LIFE

aTYR PHARMA INC Healthcare

Chief Financial Officer

CUE

Cue Biopharma, Inc. Healthcare

JMB